pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-4749 |
Genomic Coordinates | chr19: 49854591 - 49854651 |
Description | Homo sapiens miR-4749 stem-loop |
Comment | None |
RNA Secondary Structure |
Mature miRNA Information | ||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-4749-5p | |||||||||||||||||||||||||||
Sequence | 3| UGCGGGGACAGGCCAGGGCAUC |24 | |||||||||||||||||||||||||||
Evidence | Experimental | |||||||||||||||||||||||||||
Experiments | Illumina | DRVs in miRNA |
|
|||||||||||||||||||||||||
SNPs in miRNA |
|
|||||||||||||||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | SLC47A1 | ||||||||||||||||||||
Synonyms | MATE1 | ||||||||||||||||||||
Description | solute carrier family 47 member 1 | ||||||||||||||||||||
Transcript | NM_018242 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on SLC47A1 | |||||||||||||||||||||
3'UTR of SLC47A1 (miRNA target sites are highlighted) |
>SLC47A1|NM_018242|3'UTR 1 CGTGGTAGGAAAGAAAGTCAGGTCAAGTGATGCTTTTGAGCTTACACACAATTCACAGGCCCACCAGTGACAATTTACTG 81 TGAGTTAATGTCATTCAGGTGTGCCCATGGATTTTGAGGGCTGGAAATGCAAAGACACATTTTTCTATAAAAAGAAAAAG 161 CAACTAAGGTTAAAAGCTATATTGTGGCCCAAGACACTGTCTGAAAGATGACATGAGTAGTAATTCACCACTATCTGAAC 241 CAAGCAAGGATCAATGTGCTGACTGCATTGGCCAATGGCTTTGATACTTCTGCTATTTTTTTAGACACAAACCCATAAAC 321 TAACTGCTTAAGAATTCATACTGCTTGAATTATGTAAAATATATTTTACAGTATATCTTTCCTTGGGCCTTAGATTACTA 401 TTCACTGGGCAAATGGTATTTGTTTTTGTTTTAATTTTTTTTTTAATAGACGGAAGTCTTGCTCTGTCATGCAGGCTGGA 481 GTGCGGTGGTGCGATCATAGCTCACTGCAGCCTCGAACTCTTGGGCTTCAAGCAATCCTCCTGTGTCAGCCACCAGAGTA 561 GCTGAGACTACAGGGGTATGCCACCATGCCCAGCTGGCATTTGTTAATCTTCATTTGAGGTCTAGATCTAGGCACTGTGG 641 ACACTGAAAAACAGTTGGGAAATCTTTCGAGCTGTGGAAATCCAAACAAAGACTGATAATTCCTGGTAGGGGTGTGTGCG 721 TGACGTACTGCAGCCTCAACCTCCTGGGCTCAAGTGATCCTCCCACCTCAGCCTCCTGAGTAGCTGAGACCACAGGCGTG 801 TGCCACCACGCCTAGCTAATTTTTTATACCAGGGTCTACCCTTTGTTTCCCAGGCTGGTCTTGAATTCCTGGGATCAAGC 881 AATCCTTCCACCTTGCCCTCCCAAAGTGTTGGGATTATAGGCATGAGCCACCACGACTGGCCAGAGGACAAAATTTTAAT 961 AAAGGTCTTAGCTTAAGCAGTAATCCTACTTCATTAAGCCTTCCTGGGGTGCGGTACACACCGTTAATTCAGCAACCCTC 1041 AGTACATACTAAGTATGCTCAGTGCTGTGAAAGTGGATTACACCAAATTAAGTCATTCTTATCACACCCAATCAAAAGTC 1121 AAGAAGCCAGGGATAAAAGCACCTCAGGCACATAACATTAATCTAGTAATGTAATTCTCTGCACATCCAGCTGGTGAAAC 1201 TGCGTGCTGTAAGCTGGGACCAGCTTTGTCCATAACTGCTGAGAGAACTTGCTGAAGCTCTAGGAATAATTTTGCCTGCC 1281 CGGTTGCTCACCAGTTGTAGCTTGCCAGCTCCCAACACCCTTCCTGGTGCCAATAAACTTTCTCAAAGAGCAATACTGAC 1361 ATTTCTTTTGATAAAACCTCCAGCCTTCTCTGTGTTGTTCCGACATACCGAGGACCAACTGGTCTACATGGATGCCCTGA 1441 ACATGCAATTCTTTCTTCCAAAATAAAACATTAAATAGAG Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | C8166 | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM1462572. RNA binding protein: AGO2. Condition:C8166 NL4-3
... - Whisnant AW; Bogerd HP; Flores O; Ho P; et al., 2013, mBio. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Whisnant AW; Bogerd HP; Flores O; Ho P; et al. - mBio, 2013
UNLABELLED: The question of how HIV-1 interfaces with cellular microRNA (miRNA) biogenesis and effector mechanisms has been highly controversial. Here, we first used deep sequencing of small RNAs present in two different infected cell lines (TZM-bl and C8166) and two types of primary human cells (CD4(+) peripheral blood mononuclear cells [PBMCs] and macrophages) to unequivocally demonstrate that HIV-1 does not encode any viral miRNAs. Perhaps surprisingly, we also observed that infection of T cells by HIV-1 has only a modest effect on the expression of cellular miRNAs at early times after infection. Comprehensive analysis of miRNA binding to the HIV-1 genome using the photoactivatable ribonucleoside-induced cross-linking and immunoprecipitation (PAR-CLIP) technique revealed several binding sites for cellular miRNAs, a subset of which were shown to be capable of mediating miRNA-mediated repression of gene expression. However, the main finding from this analysis is that HIV-1 transcripts are largely refractory to miRNA binding, most probably due to extensive viral RNA secondary structure. Together, these data demonstrate that HIV-1 neither encodes viral miRNAs nor strongly influences cellular miRNA expression, at least early after infection, and imply that HIV-1 transcripts have evolved to avoid inhibition by preexisting cellular miRNAs by adopting extensive RNA secondary structures that occlude most potential miRNA binding sites. IMPORTANCE: MicroRNAs (miRNAs) are a ubiquitous class of small regulatory RNAs that serve as posttranscriptional regulators of gene expression. Previous work has suggested that HIV-1 might subvert the function of the cellular miRNA machinery by expressing viral miRNAs or by dramatically altering the level of cellular miRNA expression. Using very sensitive approaches, we now demonstrate that neither of these ideas is in fact correct. Moreover, HIV-1 transcripts appear to largely avoid regulation by cellular miRNAs by adopting an extensive RNA secondary structure that occludes the ability of cellular miRNAs to interact with viral mRNAs. Together, these data suggest that HIV-1, rather than seeking to control miRNA function in infected cells, has instead evolved a mechanism to become largely invisible to cellular miRNA effector mechanisms.
LinkOut: [PMID: 23592263]
|
CLIP-seq Support 1 for dataset GSM1462572 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | C8166 / C8166 NL4-3 |
Location of target site | ENST00000270570.4 | 3UTR | CCCGGUCCCCGCCGAGCUCCCCGCCGCCGCC |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23592263 / GSE59944 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||
---|---|---|---|---|---|---|---|
|
54 hsa-miR-4749-5p Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT062471 | PPTC7 | PTC7 protein phosphatase homolog | 2 | 2 | ||||||||
MIRT216687 | F2R | coagulation factor II thrombin receptor | 2 | 2 | ||||||||
MIRT452932 | DISC1 | disrupted in schizophrenia 1 | 2 | 2 | ||||||||
MIRT457070 | TOR4A | torsin family 4 member A | 2 | 2 | ||||||||
MIRT464196 | VGLL4 | vestigial like family member 4 | 2 | 4 | ||||||||
MIRT464974 | TULP1 | tubby like protein 1 | 2 | 6 | ||||||||
MIRT471714 | OTUB1 | OTU deubiquitinase, ubiquitin aldehyde binding 1 | 2 | 2 | ||||||||
MIRT473152 | MLLT1 | MLLT1, super elongation complex subunit | 2 | 2 | ||||||||
MIRT476086 | GRB2 | growth factor receptor bound protein 2 | 2 | 2 | ||||||||
MIRT477697 | EFHD2 | EF-hand domain family member D2 | 2 | 2 | ||||||||
MIRT480159 | CALR | calreticulin | 2 | 2 | ||||||||
MIRT483732 | THSD4 | thrombospondin type 1 domain containing 4 | 2 | 2 | ||||||||
MIRT484553 | BARHL1 | BarH like homeobox 1 | 2 | 6 | ||||||||
MIRT485994 | YIPF2 | Yip1 domain family member 2 | 2 | 2 | ||||||||
MIRT486530 | CLCN7 | chloride voltage-gated channel 7 | 2 | 2 | ||||||||
MIRT487220 | HIC1 | HIC ZBTB transcriptional repressor 1 | 2 | 2 | ||||||||
MIRT487799 | GPR20 | G protein-coupled receptor 20 | 2 | 4 | ||||||||
MIRT487879 | CASZ1 | castor zinc finger 1 | 2 | 4 | ||||||||
MIRT489682 | SCAMP4 | secretory carrier membrane protein 4 | 2 | 2 | ||||||||
MIRT489735 | GNAI2 | G protein subunit alpha i2 | 2 | 4 | ||||||||
MIRT489754 | TACC3 | transforming acidic coiled-coil containing protein 3 | 2 | 2 | ||||||||
MIRT489841 | HCFC1 | host cell factor C1 | 2 | 2 | ||||||||
MIRT490386 | LHFPL3 | LHFPL tetraspan subfamily member 3 | 2 | 2 | ||||||||
MIRT490584 | SLC47A1 | solute carrier family 47 member 1 | 2 | 2 | ||||||||
MIRT490722 | SLC9A3 | solute carrier family 9 member A3 | 2 | 2 | ||||||||
MIRT490741 | SRCIN1 | SRC kinase signaling inhibitor 1 | 2 | 2 | ||||||||
MIRT491705 | PDZD4 | PDZ domain containing 4 | 2 | 2 | ||||||||
MIRT491743 | SEMA3F | semaphorin 3F | 2 | 2 | ||||||||
MIRT492740 | PER1 | period circadian clock 1 | 2 | 10 | ||||||||
MIRT493162 | MKNK2 | MAP kinase interacting serine/threonine kinase 2 | 2 | 2 | ||||||||
MIRT493414 | KDM6B | lysine demethylase 6B | 2 | 2 | ||||||||
MIRT493716 | H2AFX | H2A histone family member X | 2 | 2 | ||||||||
MIRT494628 | ASB6 | ankyrin repeat and SOCS box containing 6 | 2 | 4 | ||||||||
MIRT494709 | ARHGAP31 | Rho GTPase activating protein 31 | 2 | 2 | ||||||||
MIRT495753 | PDE4C | phosphodiesterase 4C | 2 | 4 | ||||||||
MIRT499605 | ANKRD45 | ankyrin repeat domain 45 | 2 | 2 | ||||||||
MIRT501164 | SLC10A7 | solute carrier family 10 member 7 | 2 | 6 | ||||||||
MIRT502116 | KMT2D | lysine methyltransferase 2D | 2 | 2 | ||||||||
MIRT502657 | CTC1 | CST telomere replication complex component 1 | 2 | 12 | ||||||||
MIRT516766 | FAM212B | family with sequence similarity 212 member B | 2 | 4 | ||||||||
MIRT531190 | SIGLEC12 | sialic acid binding Ig like lectin 12 (gene/pseudogene) | 2 | 2 | ||||||||
MIRT531975 | C12orf49 | chromosome 12 open reading frame 49 | 2 | 2 | ||||||||
MIRT569101 | FSCN1 | fascin actin-bundling protein 1 | 2 | 2 | ||||||||
MIRT569315 | CC2D1B | coiled-coil and C2 domain containing 1B | 2 | 2 | ||||||||
MIRT569535 | CTTN | cortactin | 2 | 2 | ||||||||
MIRT569851 | RGS5 | regulator of G protein signaling 5 | 2 | 2 | ||||||||
MIRT570594 | NFIX | nuclear factor I X | 2 | 2 | ||||||||
MIRT608759 | CACNA1A | calcium voltage-gated channel subunit alpha1 A | 2 | 2 | ||||||||
MIRT616276 | HOXD11 | homeobox D11 | 2 | 2 | ||||||||
MIRT639725 | RAB17 | RAB17, member RAS oncogene family | 2 | 2 | ||||||||
MIRT661072 | PAK4 | p21 (RAC1) activated kinase 4 | 2 | 2 | ||||||||
MIRT703496 | FNDC3B | fibronectin type III domain containing 3B | 2 | 2 | ||||||||
MIRT712894 | TGFA | transforming growth factor alpha | 2 | 2 | ||||||||
MIRT721299 | C3orf36 | chromosome 3 open reading frame 36 | 2 | 2 |
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|